MoneyWorks4Me

Bharat Parenterals - Quaterly Results

06 Aug 2026 Evaluate
The Sales for the quarter ended June 2026 of Rs. 555.01 million declined by -41.19% from Rs. 943.69 millions.Net Profit of the company move down -63.43% to Rs. 36.57  millions from Rs. 99.99 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 78.78 millions from 168.74 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 555.01 943.69 -41.19 555.01 943.69 -41.19 2340.15 3041.34 -23.06
Other Income 10.53 16.20 -35.00 10.53 16.20 -35.00 125.52 145.48 -13.72
PBIDT 78.78 168.74 -53.31 78.78 168.74 -53.31 336.43 481.53 -30.13
Interest 6.93 14.17 -51.09 6.93 14.17 -51.09 34.35 47.85 -28.21
PBDT 71.85 154.57 -53.52 71.85 154.57 -53.52 302.08 433.68 -30.34
Depreciation 22.55 20.58 9.57 22.55 20.58 9.57 83.65 70.52 18.62
PBT 49.30 133.99 -63.21 49.30 133.99 -63.21 218.43 363.16 -39.85
TAX 12.73 34.00 -62.56 12.73 34.00 -62.56 58.24 98.62 -40.95
Deferred Tax -2.92 -3.04 -3.95 -2.92 -3.04 -3.95 -11.34 -7.20 57.50
PAT 36.57 99.99 -63.43 36.57 99.99 -63.43 160.19 264.54 -39.45
Equity 68.92 68.90 0.03 68.92 68.90 0.03 68.92 68.92 0.00
PBIDTM(%) 14.19 17.88 -20.62 14.19 17.88 -20.62 14.38 15.83 -9.20
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..